Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.
VA Research support for UAB clinicians and scientists has been important for six decades.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Researchers have proposed a model that resolves a seeming paradox in one of the most intriguing areas of the brain, exploring how immature granule cells in the dentate gyrus appear able to enhance pattern separation due to lesser synaptic connectivity than mature cells.
Customized deep-coverage, next-generation sequencing will replace the current state-of-the-art approach.
Open-access videos from the chair of UAB's Department of Genetics focus on the latest treatment approaches for critically ill children in all settings.
This mass spectrometry method can locate where molecular changes occur in a thin slice of tissue, and it has broad applicability to biomedical research.
Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
Greater efficiency is a must for future clinical use of these cells in regenerative medicine, drug screening and disease study.
These awards from the National Institute of Environmental Health Sciences recognize exceptional early-career scientists.
This protective effect on cardiotoxicity could benefit cancer chemotherapy recipients and heart failure patients.